The facility created more than 300 jobs and added 120,000 sq ft of manufacturing capacity. The company also announced that they will expand the site to meet the expected sustained demand for COVID-19 testing.

The new facility in Lenexa, KS has enabled production to scale from 50,000 viral transport media tubes to more than 8 million per week. Image courtesy of Thermo Fisher Scientific.

In May, the company received a contract from the U.S. government to provide a significant quantity of highly specialized VTM for COVID-19 sample collection. The VTM is dispensed into plastic tubes that are used to safely collect and transport clinical specimens containing viruses. Thermo Fisher has quickly ramped up production in Lenexa from 50,000 units per week to now more than 8 million per week.

Thermo Fisher debuts hematology/oncology assays
Thermo Fisher Scientific has debuted hematology/oncology assays that enable simultaneous analysis of DNA mutations and RNA fusion transcripts in myeloid...

Thermo Fisher's acquisition of Qiagen falls short
Thermo Fisher Scientific has terminated its acquisition of Qiagen after the company was unable to secure the number of shares needed to proceed with the...

Thermo Fisher posts 10% growth in Q2
Thermo Fisher Scientific reported financial results for the second quarter, noting 10% revenue growth.

Thermo Fisher expands COVID-19 therapies, vaccines
Thermo Fisher Scientific is expanding the development and production of COVID-19 vaccines, therapies, and additional treatments.

Thermo Fisher gets U.S. contract for COVID-19 sample collection
Thermo Fisher Scientific announced that it has received a contract from the U.S. government to provide highly specialized viral transport media for COVID-19...